Skip to content

Performance of a Hearing Aid Platform Including Different Styles of Hearing Aids

Structured Post Market Clinical Follow-up (PMCF) to Evaluate the Quality of a New Hearing Aid Product Generation.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02298452
Enrollment
253
Registered
2014-11-24
Start date
2013-05-31
Completion date
2015-09-30
Last updated
2016-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss, Bilateral or Unilateral

Brief summary

The reason for this study is to evaluate a new hearing aid product generation replacing the one on the market. The goal is to evaluate the audiological performance, usability as well as features and functions.

Detailed description

This is a controlled, single blinded comparative study which is conducted monocentric at Phonak Headquarters in Staefa. The focus is to compare a new hearing aid product generation with the one on the market as well as with competitor devices regarding the audiological performance, usability as well as features and functions with the aid of 382 mild to profound hearing impaired subjects (18-90 yrs). The subjects, all of them native (Swiss) German speakers, individually conduct a number of laboratory standard tests and home trials (questionnaires) during nine weeks including weekly appointments of 2 hours.

Interventions

DEVICEHearing aid.

The hearing aid will be fitted to the individual hearing loss of the subject.

Sponsors

Phonak AG, Switzerland
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* all kinds of hearing loss (sensorineural, conductive, combined) * all kinds of hearing loss (flat, sloping) which are in the fitting range of the hearing aids * mother tongue (swiss) german

Exclusion criteria

Subjects * with a reduced mobility unable to attend weekly study appointments * without access to a number of different hearing situations * with strongly reduced ability to describe auditory impressions and the usage of the hearing aids * which are uncooperative so that it is not possible to record a valid pure tone audiogram * with a strongly reduced dexterity * with psychological problems * central hearing disorders

Design outcomes

Primary

MeasureTime frameDescription
Difference of speech intelligibility between devices based on Quest platform and Venture platform for different hearing aid styles3 yearsFor the objective measurements in laboratory situation, both a standard German speech sentence test in noise (SRT in dB) and a standard German monosyllable word test in quiet (speech discrimination in percent) are used to compare the speech intelligibility for both platforms. The results of the Venture platform of both tests should be at least the same or better than with the Quest platform.

Secondary

MeasureTime frameDescription
Subjective ratings of speech intelligibility during home trials3 yearsFor the subjective rating of speech intelligibility, questionnaires are used to compare the current platform Quest with the new platform Venture. The subjective impressions are rated by rating scales (e.g. Speech intelligibility in quiet: everything - most - half - little - nothing).
Subjective ratings of sound quality during home trials3 yearsFor the subjective rating of sound quality, questionnaires are used to compare the current platform Quest with the new platform Venture. The subjective impressions are rated by rating scales (e.g. Sound quality for speech in quiet: good - dull - sharp - thin - echo - scratchy - unclear - noisy).
Subjective ratings of usability during home trials3 yearsFor the subjective rating of usability, questionnaires are used to compare the current platform Quest with the new platform Venture . The subjective impressions are rated by rating scales (e.g. Rating of the opening and closing of the battery door: very easy - easy - neither - difficult - very difficult).

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026